AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 FEB 5 - (NewsRx.com & NewsRx.net) -- According to recent research from Australia, "The mannose-binding lectin (MBL) pathway of complement activation is an important component of innate host defense. Numerous studies have described associations between the MBL genotype, MBL levels and disease susceptibility. However, genotyping and quantitative assays used in these studies have frequently been limited, and comprehensive data examining the interaction between structural and coding MBL genetic variants, MBL antigenic levels, and MBL functional activity are lacking."
"Such data may be important for accurate planning and interpretation of studies of MBL and disease," said R. M. Minchinton and collaborators at the Cooperative Research Centre for Vaccine Technology at the Australian Red Cross Blood Service. "This study has examined MBL in a cohort of 236 Australian blood donors. Five MBL promoter and coding single nucleotide polymorphisms were genotyped using polymerase chain reaction-sequence-specific priming (PCR-SSP). Plasma levels of MBL antigen were quantified using a double-antibody enzyme-linked immunosorbent assay (ELISA), and functional MBL levels were quantified using a mannan-binding assay. Activation of the complement pathway by MBL was measured in a C4-deposition assay."
The researchers concluded, ...